about
The concept of immune surveillance against tumors. The first theoriesPan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cellsMolecular study of the perforin gene in familial hematological malignancies.Perforin gene mutations in 77 Chinese patients with lymphomas.Applications of biological pores in nanomedicine, sensing, and nanoelectronicsDevelopment of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutationsIntravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.Interferon-Gamma Receptor Signaling Plays an Important Role in Restraining Murine Ovarian Tumor Progression.Co-expression of perforin and granzyme B genes induces apoptosis and inhibits the tumorigenicity of laryngeal cancer cell line Hep-2.Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene.Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning.Inherited defects in lymphocyte cytotoxic activity.Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas.Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis.T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.Inherited defects causing hemophagocytic lymphohistiocytic syndrome
P2860
Q28073937-2FE9038D-572C-4757-9784-E89FEDB4F76AQ28485258-261CAE73-7C48-4C48-8763-E7C8AF9A2CF6Q30407331-7A547C5A-4F22-4AC8-9CAB-9234423D0F7AQ34032198-407B2C5C-9E3F-4BD1-AFC6-AB0D227A3D8DQ35063550-B4BF4121-98D5-4199-80D2-2F79E61AD09FQ36805860-C00206AA-C3F9-4E96-B6C2-54F81BC05C15Q37260460-72DDED57-25C8-4EF2-9229-EEBA7CE863E6Q37350929-14EE8E73-0B60-49BC-A7A0-F43E1773DA1EQ37676738-72D0432E-158A-4B75-97B5-A889E901482BQ37690225-BEA881FB-1182-4F43-9643-C23811D14267Q37719014-69C48515-8C28-4BAB-9766-C2B0C1A8D7A7Q37763991-D82CD5EA-9DF8-4FDC-AC32-415147A4F7F7Q38447992-CB3455C8-0449-4CE6-A756-18D3316BA756Q44249895-82FD9C19-DD51-4D00-BBC6-2333166ADDDDQ46511830-31D99F9C-4098-4399-99C1-D3DBCEFBF2CBQ47217197-D3401F54-EB81-4A33-8D16-7F86FBCD9372Q57965153-F43F73AE-5D36-4BCE-9756-C6A87157B8D5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Perforin-mediated suppression of B-cell lymphoma
@en
Perforin-mediated suppression of B-cell lymphoma.
@nl
type
label
Perforin-mediated suppression of B-cell lymphoma
@en
Perforin-mediated suppression of B-cell lymphoma.
@nl
prefLabel
Perforin-mediated suppression of B-cell lymphoma
@en
Perforin-mediated suppression of B-cell lymphoma.
@nl
P2093
P2860
P50
P356
P1476
Perforin-mediated suppression of B-cell lymphoma
@en
P2093
Duncan Macgregor
Jennifer A Westwood
Paul Bolitho
Paul Waring
Shayna E A Street
William K Murray
Winfried Edelmann
P2860
P304
P356
10.1073/PNAS.0809008106
P407
P577
2009-02-05T00:00:00Z